Camlin Fine Sciences · NSE: CAMLINFINE · BSE: 532834
Q4 FY24 results · Jan–Mar 2024
Camlin Fine Sciences reported revenue from operations of ₹401.69 crore (down 5.9% from Q4 FY23) and net loss of ₹81.79 crore for Q4 FY24 (Jan–Mar 2024), on a consolidated basis.
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 401.69 | 426.71 | −5.9% | 385.89 | +4.1% |
| Other income | 5.76 | 2.00 | +188.7% | 1.66 | +246.3% |
| Total income | 407.46 | 428.70 | −5.0% | 387.55 | +5.1% |
| Profit before tax | (93.51) | 8.43 | Turned loss | (9.73) | Loss widened |
| Net profit for the period | (81.79) | 3.48 | Turned loss | (14.28) | Loss widened |
| Attributable to shareholders of the company | (77.14) | 9.16 | Turned loss | (11.79) | Loss widened |
| EPS, basic (₹) | (4.64) | 0.59 | Turned loss | (0.71) | Loss widened |
| Net margin (%) | -20.4 | 0.8 | -3.7 |
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 220.33 | 218.16 | +1.0% | 185.61 | +18.7% |
| Other income | 5.55 | 1.24 | +348.4% | 2.13 | +161.2% |
| Total income | 225.88 | 219.40 | +3.0% | 187.73 | +20.3% |
| Profit before tax | (48.68) | 11.44 | Turned loss | (17.69) | Loss widened |
| Net profit for the period | (44.07) | 7.80 | Turned loss | (11.64) | Loss widened |
| EPS, basic (₹) | (2.65) | 0.51 | Turned loss | (0.70) | Loss widened |
| Net margin (%) | -20.0 | 3.6 | -6.3 |
Consolidated
- Filed with BSE
- 21 May 2024, 16:49 IST
- Board meeting
- 20 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 21 May 2024, 16:49 IST
- Board meeting
- 20 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Audited
- Source
- XBRL filing on BSE